Drug Trial Radar · NCT07219511
A Safety, Tolerability, and Biomarker Trial of VS-041 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)
Last checked: Nov 20, 2026Latest source record: Oct 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
42
Planned (sponsor's estimate)
Start
Nov 4, 2025
Primary completion
Nov 2026
Study completion Dec 2026
Sponsor
- Lead sponsor
- Vasa TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Oct 22, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 50 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A Safety, Tolerability, and Biomarker Trial of VS-041 in Participants with Heart Failure with Preserved Ejection Fraction (HFpEF)
Conditions
- Heart
- Heart Failure With Preserved Ejection Fraction (HFPEF)
Interventions
VS-041Drug
VS-041 high dose, VS-041 low dose or Placebo tablet BID
PlaceboOther
Placebo to match VS-041
Primary outcomes
What the sponsor says the trial is designed to measure.
- Participant incidence of treatment-emergent adverse events (TEAEs)Time frame: From Baseline to Day 28
- Change from baseline over time in serum NordicPRO-C6Time frame: From Baseline to Day 28
- Change from baseline over time in serum endotrophinTime frame: From Baseline to Day 28
- Change from baseline over time in serum NT-proBNPTime frame: From Baseline to Day 28
Locations
21 sites in 1 country. Site status is shown where the registry gives one.
Cardiology and Medicine Clinic
Little Rock, Arkansas
National Institute of Clinical Research
Huntington Beach, California
FOMAT
Santa Maria, California
Invivocure LLC
Van Nuys, California
New Generation of Medical Research
Hialeah, Florida
Jacksonville Center for Clinical Research
Jacksonville, Florida
Amavita Health
North Miami Beach, Florida
Broward Research Center
Pembroke Pines, Florida
Eagle Clinical Research
Chicago, Illinois
Chicago Medical Research
Hazel Crest, Illinois
Methodist Medical Center of Illinois
Peoria, Illinois
Louisiana Heart Center
Slidell, Louisiana
Washington University
St Louis, Missouri
Ash Research Clinic
Brick, New Jersey
Erie County Medical Center
Buffalo, New York
Duke University Medical Center
Durham, North Carolina
Wake Forest
Winston-Salem, North Carolina
Cleveland Clinic
Cleveland, Ohio
Oklahoma Heart Hospital
Oklahoma City, Oklahoma
University of Texas Southwestern Medical Center
Dallas, Texas
LinQ Research, LLC
Tomball, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.